242 related articles for article (PubMed ID: 37263167)
41. Oxyberberine ameliorates TNBS-induced colitis in rats through suppressing inflammation and oxidative stress via Keap1/Nrf2/NF-κB signaling pathways.
Li C; Liu M; Deng L; Luo D; Ma R; Lu Q
Phytomedicine; 2023 Jul; 116():154899. PubMed ID: 37247589
[TBL] [Abstract][Full Text] [Related]
42. Phosphatidylinositol 3-kinase signaling pathway and inflammatory bowel disease: Current status and future prospects.
Jalil AT; Hassan NF; Abdulameer SJ; Farhan ZM; Suleiman AA; Al-Azzawi AK; Zabibah R; Fadhil A
Fundam Clin Pharmacol; 2023 Oct; 37(5):910-917. PubMed ID: 36939850
[TBL] [Abstract][Full Text] [Related]
43. Maresin 1 alleviates dextran sulfate sodium-induced ulcerative colitis by regulating NRF2 and TLR4/NF-kB signaling pathway.
Qiu S; Li P; Zhao H; Li X
Int Immunopharmacol; 2020 Jan; 78():106018. PubMed ID: 31780371
[TBL] [Abstract][Full Text] [Related]
44. Target-Based Small Molecule Drug Discovery Towards Novel Therapeutics for Inflammatory Bowel Diseases.
Li Y; Chen J; Bolinger AA; Chen H; Liu Z; Cong Y; Brasier AR; Pinchuk IV; Tian B; Zhou J
Inflamm Bowel Dis; 2021 Nov; 27(Suppl 2):S38-S62. PubMed ID: 34791293
[TBL] [Abstract][Full Text] [Related]
45. Mechanisms underlying the perifocal neuroprotective effect of the Nrf2-ARE signaling pathway after intracranial hemorrhage.
Yin XP; Chen ZY; Zhou J; Wu D; Bao B
Drug Des Devel Ther; 2015; 9():5973-86. PubMed ID: 26604696
[TBL] [Abstract][Full Text] [Related]
46. Targeting JAK/STAT signaling pathways in treatment of inflammatory bowel disease.
Wang L; Hu Y; Song B; Xiong Y; Wang J; Chen D
Inflamm Res; 2021 Jul; 70(7):753-764. PubMed ID: 34212215
[TBL] [Abstract][Full Text] [Related]
47. Protective effect of ShaoYao decoction on colitis-associated colorectal cancer by inducing Nrf2 signaling pathway.
Wang X; Saud SM; Wang F; He S; Zhang X; Hua B; Li W
J Ethnopharmacol; 2020 Apr; 252():112600. PubMed ID: 31981745
[TBL] [Abstract][Full Text] [Related]
48. Perillyl alcohol attenuates chronic restraint stress aggravated dextran sulfate sodium-induced ulcerative colitis by modulating TLR4/NF-κB and JAK2/STAT3 signaling pathways.
Puppala ER; Aochenlar SL; Shantanu PA; Ahmed S; Jannu AK; Jala A; Yalamarthi SS; Borkar RM; Tripathi DM; Naidu VGM
Phytomedicine; 2022 Nov; 106():154415. PubMed ID: 36070663
[TBL] [Abstract][Full Text] [Related]
49. Counteracting role of nuclear factor erythroid 2-related factor 2 pathway in Alzheimer's disease.
Sharma V; Kaur A; Singh TG
Biomed Pharmacother; 2020 Sep; 129():110373. PubMed ID: 32603894
[TBL] [Abstract][Full Text] [Related]
50. Colon-Accumulated Gold Nanoclusters Alleviate Intestinal Inflammation and Prevent Secondary Colorectal Carcinogenesis via Nrf2-Dependent Macrophage Reprogramming.
Lu C; Xue L; Luo K; Liu Y; Lai J; Yao X; Xue Y; Huo W; Meng C; Xia D; Gao X; Yuan Q; Cao K
ACS Nano; 2023 Sep; 17(18):18421-18432. PubMed ID: 37690027
[TBL] [Abstract][Full Text] [Related]
51. Linagliptin mitigates experimental inflammatory bowel disease in rats by targeting inflammatory and redox signaling.
Arab HH; Eid AH; Mahmoud AM; Senousy MA
Life Sci; 2021 May; 273():119295. PubMed ID: 33667522
[TBL] [Abstract][Full Text] [Related]
52. Personalized redox medicine in inflammatory bowel diseases: an emerging role for HIF-1α and NRF2 as therapeutic targets.
Bourgonje AR; Kloska D; Grochot-Przęczek A; Feelisch M; Cuadrado A; van Goor H
Redox Biol; 2023 Apr; 60():102603. PubMed ID: 36634466
[TBL] [Abstract][Full Text] [Related]
53. Natural Nuclear Factor Kappa Beta Inhibitors: Safe Therapeutic Options for Inflammatory Bowel Disease.
Tambuwala MM
Inflamm Bowel Dis; 2016 Mar; 22(3):719-23. PubMed ID: 26717321
[TBL] [Abstract][Full Text] [Related]
54. Novel therapeutic targets for inflammatory bowel disease.
Argollo M; Fiorino G; Hindryckx P; Peyrin-Biroulet L; Danese S
J Autoimmun; 2017 Dec; 85():103-116. PubMed ID: 28711286
[TBL] [Abstract][Full Text] [Related]
55. Stepwise tracking strategy to screen ingredient from Galla Chinensis based on the "mass spectrometry guided preparative chromatography coupled with systems pharmacology".
Wang Z; Xue R; Lv M; Qi Y; Yu W; Xie Z; Chen W; Wang X; Tian X; Han B
J Ethnopharmacol; 2022 Feb; 284():114533. PubMed ID: 34728319
[TBL] [Abstract][Full Text] [Related]
56. Signaling molecules: the pathogenic role of the IL-6/STAT-3 trans signaling pathway in intestinal inflammation and in colonic cancer.
Atreya R; Neurath MF
Curr Drug Targets; 2008 May; 9(5):369-74. PubMed ID: 18473764
[TBL] [Abstract][Full Text] [Related]
57. Vitamin D in inflammatory bowel disease: From biology to clinical implications.
Parizadeh SM; Jafarzadeh-Esfehani R; Hassanian SM; Mottaghi-Moghaddam A; Ghazaghi A; Ghandehari M; Alizade-Noghani M; Khazaei M; Ghayour-Mobarhan M; Ferns GA; Parizadeh SMR; Avan A
Complement Ther Med; 2019 Dec; 47():102189. PubMed ID: 31779998
[TBL] [Abstract][Full Text] [Related]
58. Aged garlic extract enhances heme oxygenase-1 and glutamate-cysteine ligase modifier subunit expression via the nuclear factor erythroid 2-related factor 2-antioxidant response element signaling pathway in human endothelial cells.
Hiramatsu K; Tsuneyoshi T; Ogawa T; Morihara N
Nutr Res; 2016 Feb; 36(2):143-9. PubMed ID: 26507778
[TBL] [Abstract][Full Text] [Related]
59. Cardioprotective Effects of Natural Products
Tavakoli R; Tabeshpour J; Asili J; Shakeri A; Sahebkar A
Curr Vasc Pharmacol; 2021; 19(5):525-541. PubMed ID: 33155913
[TBL] [Abstract][Full Text] [Related]
60. Patients' perspectives on smoking and inflammatory bowel disease: An online survey in collaboration with European Federation of Crohn's and Ulcerative Colitis Associations.
Le Berre C; Loy L; Lönnfors S; Avedano L; Piovani D
World J Gastroenterol; 2020 Aug; 26(29):4343-4355. PubMed ID: 32848338
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
